Astellas Patient Assistance Program
The Astellas Patient Assistance Programa provides Myrbetriq® (mirabegron) extended-release tablets at no cost to patients who meet the program eligibility requirements.
Myrbetriq Support Solutionsb can assess whether you are eligible for enrollment. For more information, contact us at 1-800-477-6472. We are available Monday–Friday, 9:00 am–8:00 pm ET.
You may be eligible if you meet the following criteria:
- Be uninsured or have insurance that excludes coverage for Myrbetriq
- Have a verifiable shipping address within the United States
- Have been prescribed Myrbetriq for an FDA-approved indication
- Meet the program financial eligibility requirements
If you meet the program requirements, your healthcare provider can start the application process by submitting the Patient Enrollment Form that includes the necessary information for us to assess your eligibility.
Once you are approved for the Astellas Patient Assistance Program, we will notify both you and your healthcare provider that you have been enrolled. A supply of Myrbetriq will then be shipped directly to your home.
a The program is void where prohibited by law.
b Myrbetriq Support Solutions is a component of Astellas Pharma Support SolutionsSM.
Myrbetriq® is a registered trademark of Astellas Pharma Inc.